Asset Details
Do you wish to reserve the book?
The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
Do you wish to request the book?
The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
2018
Overview
Background
It is well known that angiopoietin-like protein 8 (ANGPTL8) exerts its effects on lipid metabolism through the inhibition of lipoprotein lipase and subsequent elevation of plasma triglyceride. However, it is not clear whether ANGPTL8 could affect lipid metabolism via other pathways. The study was aimed to investigate the effects of ANGPTL8 on the function of high-density lipoprotein (HDL), which plays a protective role in atherosclerosis progression.
Methods
Two hundred and ten subjects were recruited. Plasma ANGPTL8 was measured by enzyme-linked immunosorbent assays. Cholesterol efflux capacity was chosen as the biomarker of HDL function and measured via H
3
-cholesterol loading THP-1 cell models.
Results
ANGPTL8 exhibited no significant difference between CAD group and nonCAD group, but ANGPTL8 in DM group was significantly higher than that in the nonDM group [568.3 (406.2–836.8) vs 458.2 (356.8–755.6), P = 0.023]. Compared to controls, subjects in CAD group and DM group exhibited significantly lower cholesterol efflux capacity [CAD: 14.58 ± 2.06 vs 12.51 ± 2.83%, P < 0.0001; DM: 13.62 ± 2.57 vs 12.34 ± 3.16%, P = 0.0099]. ANGPTL8 was inversely correlated with cholesterol efflux capacity (r = − 0.188, P < 0.01). Regression analysis revealed that plasma ANGPTL8 was an independent contributor to cholesterol efflux capacity (standardized β = − 0.143, P = 0.023).
Conclusion
ANGPTL8 presents a negative effect on HDL-mediated cholesterol efflux capacity.
Publisher
BioMed Central,Springer Nature B.V,BMC
Subject
Acute Coronary Syndrome - blood
/ Acute Coronary Syndrome - diagnosis
/ Aged
/ Angiopoietin-like Proteins - blood
/ ANGPTL8
/ Diabetes
/ Diabetes Mellitus, Type 2 - blood
/ Diabetes Mellitus, Type 2 - diagnosis
/ Enzymes
/ Female
/ Humans
/ Lipase
/ Lipids
/ Male
/ Medicine
/ Patients
/ Proteins
/ Studies
